Home > Quotes > NVO > Company News

Novo Nordisk A/S News Headlines

NVO 
$171.14
*  
0.54
  negative  
0.31%
Get NVO Alerts
*Delayed - data as of May 21, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

A Look Back At The Year In Pharmaceuticals (PFE, SNY, NVO, AZN)
12/28/2012 1:05:00 PM - Investopedia

Raptor Drug FDA Action Date Delayed - Analyst Blog
12/28/2012 9:10:01 AM - Zacks.com

Acorda Completes Acquisition of Neuronex - Analyst Blog
12/27/2012 6:15:01 PM - Zacks.com

EU Approval for Novartis' Exjade - Analyst Blog
12/27/2012 5:52:01 PM - Zacks.com

Oncothyreon/Merck KGaA Drug Fails - Analyst Blog
12/27/2012 4:37:01 PM - Zacks.com

Japanese Approval for Eliquis - Analyst Blog
12/27/2012 10:40:01 AM - Zacks.com

Pfizer Signs a Couple of Deals - Analyst Blog
12/26/2012 4:50:01 PM - Zacks.com

SNY to Expand Animal Health Business - Analyst Blog
12/26/2012 1:45:01 PM - Zacks.com

Merck's Tredaptive Fails in Study - Analyst Blog
12/26/2012 12:20:01 PM - Zacks.com

Comparing Dividend Payout Ratios Across Regions
12/26/2012 8:58:00 AM - Seeking Alpha

Glaxo/Amicus' Fabry Drug Disappoints - Analyst Blog
12/21/2012 1:14:01 PM - Zacks.com

NVO Progresses with Pipeline - Analyst Blog
12/20/2012 5:06:01 PM - Zacks.com

Glaxo/THRX's COPD Candidate Advances - Analyst Blog
12/20/2012 10:50:01 AM - Zacks.com

Positive News for AstraZeneca - Analyst Blog
12/20/2012 9:20:01 AM - Zacks.com

Good News for AstraZeneca - Analyst Blog
12/19/2012 3:45:01 PM - Zacks.com

Merck Ties Up with GE Healthcare - Analyst Blog
12/19/2012 10:50:01 AM - Zacks.com

Glaxo's Anthrax Drug Gets FDA Nod - Analyst Blog
12/18/2012 6:20:01 PM - Zacks.com

US Approval for Novartis' Signifor - Analyst Blog
12/17/2012 5:00:01 PM - Zacks.com

Eli Lilly Scraps a Phase III Study - Analyst Blog
12/17/2012 12:20:01 PM - Zacks.com

AstraZeneca's RA Drug Disappoints - Analyst Blog
12/14/2012 6:10:01 PM - Zacks.com

J&J Files NDA for Combo Diabetes Drug - Analyst Blog
12/14/2012 12:10:01 PM - Zacks.com

Sanofi Presents Positive Results - Analyst Blog
12/13/2012 2:30:01 PM - Zacks.com

BMY/ABT Present Oncology Data - Analyst Blog
12/12/2012 2:30:01 PM - Zacks.com

7 High Growth Healthcare Stocks With Strong Inventory Trends
12/12/2012 1:19:00 AM - Seeking Alpha

Should The Amylin Example Discourage Amarin Shareholders?
12/7/2012 5:35:00 PM - Seeking Alpha